Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026
The most important clinical decision with Lupus Foot Symptoms: How Systemic Lupus Erythematosus Affects the Feet isn’t which treatment to choose — it’s identifying which subtype you have first. Our podiatrists see patients treated for the wrong subtype for months before the correct diagnosis leads to full resolution. Call (810) 206-1402 — expert podiatric care across Michigan.

Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems, and the feet and ankles are frequently involved. For many patients, foot and ankle symptoms are among the first manifestations of lupus — and for those already diagnosed, managing foot complications is an ongoing part of lupus care. Podiatrists and rheumatologists work closely in managing the foot manifestations of this complex disease.
How Lupus Affects the Feet
Lupus produces foot symptoms through several distinct mechanisms. Arthritis — the most common lupus foot complaint — results from immune complex deposition in joints, producing synovitis. Vasculitis and Raynaud’s phenomenon affect blood flow to the toes and feet. Skin manifestations include livedo reticularis (mottled vascular pattern), discoid lesions, and vasculitic ulcers. Avascular necrosis of the talus and other foot bones can result from prolonged corticosteroid treatment (a common lupus medication) or from lupus-associated antiphospholipid antibody syndrome. Neuropathy and myopathy from lupus itself or from immunosuppressive medications can cause weakness and sensory changes.
Lupus Foot and Ankle Manifestations
| Manifestation | Prevalence in SLE | Presentation | Mechanism | Treatment Approach |
|---|---|---|---|---|
| Arthritis / synovitis (Jaccoud’s arthropathy) | ~70% have joint involvement | Painful swollen joints; often non-erosive but can produce deformity; MTP and ankle joints common | Immune complex-mediated synovitis; tendon laxity from inflammation | NSAIDs (with caution — lupus nephritis); hydroxychloroquine; systemic immunosuppression |
| Raynaud’s phenomenon | ~30–40% | Triphasic color change (white→blue→red) of toes with cold exposure; numbness during white phase | Vasospasm; endothelial dysfunction; often secondary to underlying connective tissue disease | Avoid cold; calcium channel blockers; sympatholytic agents; vasodilators |
| Livedo reticularis | Common | Mottled, net-like vascular pattern on skin of feet and lower legs; worsens with cold | Cutaneous vascular pattern; associated with antiphospholipid antibody syndrome in some patients | Treat underlying lupus; anticoagulation if associated with antiphospholipid syndrome |
| Vasculitic ulcers | ~15–20% with skin involvement | Painful ulcers at tips of toes or on the foot; punched-out appearance; surrounding erythema | Leukocytoclastic vasculitis; cutaneous vessel inflammation | Wound care; immunosuppression; vascular evaluation if severe |
| Avascular necrosis (AVN) | ~10–15% of SLE patients on chronic steroids | Joint pain with activity; most common in hip but talus and other foot bones affected | Corticosteroid-induced or antiphospholipid syndrome; impaired bone blood supply | Early: activity modification; advanced: surgical (core decompression, osteotomy, or joint replacement) |
| Tendon laxity / hammer toes / flat feet | Common in longstanding disease | Progressive foot deformity; arch collapse; hammertoes; forefoot splaying | Chronic synovitis and joint capsule laxity; periarticular tissue damage | Custom orthotics; supportive footwear; surgical if severe deformity |
| Peripheral neuropathy | ~10–21% | Burning, tingling, numbness in feet; stocking distribution | Vasculitic neuropathy; metabolic effects; medication side effects | Pain management; treat underlying lupus; review medications |
Medication Effects on the Feet in Lupus Patients
| Medication | Foot-Related Side Effect | Management |
|---|---|---|
| Corticosteroids (prednisone) | AVN (talus, other bones); Cushingoid fat redistribution; steroid-induced diabetes leading to neuropathy; skin fragility | Minimize dose/duration; bone density monitoring; early AVN screening in high-risk patients |
| Hydroxychloroquine (Plaquenil) | Rare peripheral myopathy at high doses; generally foot-safe | Annual eye exams as per protocol; minimal foot-specific monitoring needed |
| Methotrexate | Increased infection risk; impaired wound healing; folate supplementation reduces mucositis risk (relevant for oral sores) | Monitor for infections; take folic acid supplementation; careful wound care |
| Mycophenolate mofetil | Increased infection risk; possible peripheral edema | Edema: compression stockings; infection: prompt evaluation of any foot wound |
| Belimumab, anifrolumab (biologics) | Infection risk; injection site reactions | Prompt evaluation of any foot infection or wound |
Podiatry’s Role in Lupus Management
Podiatrists contribute to lupus care in several specific ways. Regular foot inspection and nail care is especially important for lupus patients on immunosuppressive therapy, where minor wounds can progress rapidly. Custom orthotics and footwear modification manage Jaccoud’s arthropathy deformities and reduce plantar pressure on vasculitic areas. Wound management of vasculitic ulcers requires specialized care coordinated with rheumatology. Early recognition of AVN symptoms leads to timely imaging and earlier-stage surgical intervention when needed. Collaboration between rheumatology and podiatry produces better outcomes for patients with significant foot involvement.
Balance Foot & Ankle coordinates with rheumatologists for patients with SLE and other connective tissue diseases. Call (810) 206-1402 for evaluation at Howell or Bloomfield Hills.
PubMed: Lupus and Foot/Ankle Manifestations
PubMed: Lupus and Foot/Ankle Manifestations
Ready to Get Relief?
Same-day appointments available in Howell & Bloomfield Hills, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Doctor Answer
How does lupus affect the feet?
Lupus (SLE) affects the feet through several mechanisms: small vessel vasculitis causes Raynaud’s phenomenon and ischemic toe changes; arthritis of the ankle and small foot joints causes pain and swelling; peripheral neuropathy produces numbness and tingling; and skin manifestations including purpura and livedo reticularis appear on the feet and legs. Avascular necrosis of the talus from prolonged corticosteroid use is a serious complication. I manage lupus-related foot problems in coordination with rheumatology, focusing on symptom management and preventing complications.
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.